Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
26,49 USD | +2,32% | +2,71% | +16,90% |
14/03 | ANIKA THERAPEUTICS, INC. : Barrington Research herhaalt koopadvies | ZM |
13/03 | Transcript : Anika Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 |
Vakgebied
Aantal werknemers: 357
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Ostoarthritis Pain Management
61,2
%
| 98 | 62,7 % | 102 | 61,2 % | +4,13% |
Joint Preservation and Restoration
32,9
%
| 50 | 32,3 % | 55 | 32,9 % | +8,88% |
Non-Orthopedic
5,9
%
| 8 | 5,1 % | 10 | 5,9 % | +24,02% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
73,9
%
| 119 | 76,3 % | 123 | 73,9 % | +3,34% |
Other
13,1
%
| 16 | 10,5 % | 22 | 13,1 % | +32,61% |
Europe
13,0
%
| 21 | 13,2 % | 22 | 13,0 % | +5,26% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Cheryl Blanchard
CEO | Chief Executive Officer | 59 | 31-08-18 |
Michael Levitz
DFI | Director of Finance/CFO | 50 | 10-08-20 |
Anne Nunes
COO | Chief Operating Officer | 55 | 01-09-21 |
Mira Leiwant
CTO | Chief Tech/Sci/R&D Officer | - | 14-10-19 |
Steven Ek
CTO | Chief Tech/Sci/R&D Officer | - | 29-05-20 |
Mark Namaroff
IRC | Investor Relations Contact | 60 | - |
Lisa Funiciello
HRO | Human Resources Officer | - | 01-02-22 |
David Colleran
LAW | General Counsel | 52 | 04-03-20 |
James Chase
SAM | Sales & Marketing | - | 06-08-18 |
Ian McLeod
AUD | Comptroller/Controller/Auditor | - | 01-07-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Susan Vogt
BRD | Director/Board Member | 70 | 23-10-18 |
Sheryl Conley
BRD | Director/Board Member | 63 | 28-10-21 |
Cheryl Blanchard
CEO | Chief Executive Officer | 59 | 31-08-18 |
John Henneman
CHM | Chairman | 62 | 03-09-20 |
Glenn Larsen
BRD | Director/Board Member | 70 | 17-02-15 |
Gary Fischetti
BRD | Director/Board Member | 63 | 13-04-23 |
Jeffery Thompson
BRD | Director/Board Member | 58 | 18-01-11 |
Stephen Richard
BRD | Director/Board Member | 61 | 03-09-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 15 016 456 | 14 388 223 ( 95,82 %) | 188 000 ( 1,252 %) | 95,82 % |
Bedrijfsgegevens
Anika Therapeutics, Inc.
32 Wiggins Avenue
01730, Bedford
+781 457 9000
http://www.anikatherapeutics.comSector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,90% | 380 mln. | |
-4,24% | 86,85 mld. | |
+2,76% | 40,16 mld. | |
-16,48% | 31,28 mld. | |
+57,86% | 25,27 mld. | |
-13,58% | 15,33 mld. | |
-9,12% | 11,96 mld. | |
-42,56% | 11,61 mld. | |
+6,89% | 8,83 mld. | |
-10,53% | 7,94 mld. |
- Beurs
- Aandelen
- Koers ANIK
- Onderneming Anika Therapeutics, Inc.